Literature DB >> 20850887

Renal and circulatory dysfunction in cirrhosis: current management and future perspectives.

Elsa Solà1, Pere Ginès.   

Abstract

Chronic liver diseases are amongst the top leading causes of death in Europe as well as in other areas of the world. Chronic liver diseases are characterized by unrelenting progression of liver inflammation and fibrosis over a prolonged period of time, usually more than 20 years, which may eventually lead to cirrhosis. Advanced cirrhosis leads to a complex syndrome of chronic liver failure which involves many different organs besides the liver, including the brain, heart and systemic circulation, adrenal glands, lungs, and kidneys. The high morbidity and mortality secondary to chronic liver failure is due to complications related to the dysfunction of these organs, either alone or, more frequently, in combination. Understanding the mechanisms leading to organ dysfunction is crucial to the development of strategies for treatment and prevention of complications of cirrhosis. This article reviews our current knowledge, as well as future perspectives, on the management of circulatory and renal dysfunction in chronic liver failure.

Entities:  

Mesh:

Year:  2010        PMID: 20850887     DOI: 10.1016/j.jhep.2010.08.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  27 in total

1.  Hepatobiliary quiz-7 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-09

2.  Hemodynamic phenotype of the failing Fontan in an adult population.

Authors:  Camden L Hebson; Nancy M McCabe; Robert W Elder; William T Mahle; Michael McConnell; Brian E Kogon; Emir Veledar; Maan Jokhadar; Robert N Vincent; Anurag Sahu; Wendy M Book
Journal:  Am J Cardiol       Date:  2013-09-25       Impact factor: 2.778

Review 3.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

4.  Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion.

Authors:  A D Fialla; O B Schaffalitzky de Muckadell; P Bie; H C Thiesson
Journal:  BMC Nephrol       Date:  2018-09-19       Impact factor: 2.388

5.  Parallel TIPS for treatment of refractory ascites and hepatic hydrothorax.

Authors:  Ahmad Parvinian; Ron C Gaba
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

6.  Risk stratification of spontaneous bacterial peritonitis in cirrhosis with ascites based on classification and regression tree analysis.

Authors:  Ke-Qing Shi; Yu-Chen Fan; Li Ying; Xian-Feng Lin; Mei Song; Ling-Fei Li; Xie-Yan Yu; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Mol Biol Rep       Date:  2011-12-29       Impact factor: 2.316

Review 7.  The Kidney in Pediatric Liver Disease.

Authors:  Robyn Greenfield Matloff; Ronen Arnon
Journal:  Curr Gastroenterol Rep       Date:  2015-09

Review 8.  Beyond a broken heart: circulatory dysfunction in the failing Fontan.

Authors:  Makoto Mori; Alfredo J Aguirre; Robert W Elder; Ali Kashkouli; Alton Brad Farris; Ryan M Ford; Wendy M Book
Journal:  Pediatr Cardiol       Date:  2014-02-15       Impact factor: 1.655

9.  Tumor necrosis factor-α and interleukin-6 in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  Muhammed Am Suliman; Fawzy Mh Khalil; Salam Sa Alkindi; Anil V Pathare; Ali Aa Almadhani; Neveen Aai Soliman
Journal:  World J Gastrointest Pathophysiol       Date:  2012-10-15

10.  Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease.

Authors:  Yun Soo Hong; Dong Hyun Sinn; Geum-Youn Gwak; Juhee Cho; Danbee Kang; Yong-Han Paik; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.